(Q36531721)

14 August 2017

1 reference

title

Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients (English)

1 reference

14 August 2017

1 reference

Zahida Bhatti

1

1 reference

14 August 2017

Aasma Shaukat

series ordinal

2

1 reference

14 August 2017

Nikolaos G Almyroudis

series ordinal

3

1 reference

14 August 2017

Brahm H Segal

series ordinal

4

1 reference

14 August 2017

publication date

1 July 2006

1 reference

14 August 2017

number of pages

15

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

14 August 2017

volume

162

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

1-15

1 reference

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11046-006-0025-X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-006-0025-X

Emergence of black moulds in fungal disease: epidemiology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-006-0025-X

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-006-0025-X

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

12 December 2020

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

1 reference

12 December 2020

Impact of previous aspergillosis on the outcome of bone marrow transplantation

1 reference

12 December 2020

Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections

1 reference

12 December 2020

Posaconazole as salvage therapy for zygomycosis

1 reference

12 December 2020

Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex

1 reference

12 December 2020

Immunity to fungal infections

1 reference

12 December 2020

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

12 December 2020

Infections due to emerging and uncommon medically important fungal pathogens

1 reference

12 December 2020

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

12 December 2020

Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

12 December 2020

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

12 December 2020

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin

1 reference

12 December 2020

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

12 December 2020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

12 December 2020

Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management

1 reference

12 December 2020

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

12 December 2020

Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer

1 reference

12 December 2020

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

1 reference

12 December 2020

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

12 December 2020

Tumor necrosis factor inhibition and invasive fungal infections

1 reference

12 December 2020

Current approaches to diagnosis and treatment of invasive aspergillosis

1 reference

12 December 2020

Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression

1 reference

12 December 2020

Immunotherapy for fungal infections

1 reference

12 December 2020

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction

1 reference

12 December 2020

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

1 reference

12 December 2020

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

12 December 2020

Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery

1 reference

12 December 2020

An approach to the diagnosis of pulmonary infections in immunosuppressed patients

1 reference

12 December 2020

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

12 December 2020

Vaccinate against aspergillosis! A call to arms of the immune system.

1 reference

12 December 2020

Zygomycosis in the 1990s in a tertiary-care cancer center

1 reference

12 December 2020

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis

1 reference

12 December 2020

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

12 December 2020

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

12 December 2020

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy

1 reference

12 December 2020

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

12 December 2020

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

12 December 2020

Fusarium infection in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

12 December 2020

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

12 December 2020

Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation

1 reference

12 December 2020

Rapid diagnosis of invasive aspergillosis by antigen detection

1 reference

12 December 2020

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

12 December 2020

Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

12 December 2020

Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

1 reference

12 December 2020

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

12 December 2020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

12 December 2020

Design of efficacy trials of cytokines in combination with antifungal drugs.

1 reference

12 December 2020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

12 December 2020

Efficacy of micafungin alone or in combination against systemic murine aspergillosis

1 reference

12 December 2020

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

12 December 2020

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

12 December 2020

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

12 December 2020

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

12 December 2020

Posaconazole: a broad-spectrum triazole antifungal

1 reference

12 December 2020

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

12 December 2020

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

1 reference

12 December 2020

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

1 reference

12 December 2020

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

1 reference

12 December 2020

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

12 December 2020

Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients

1 reference

12 December 2020

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

1 reference

12 December 2020

10.1007/S11046-006-0025-X

Identifiers

DOI

1 reference

14 August 2017

1 reference